Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Xeris Pharmaceuticals (XERS) just unveiled an announcement.
Xeris Biopharma Holdings, Inc. has announced the promotion of Kevin McCulloch to President and Chief Operating Officer starting August 1, 2024, with an impressive career background including senior roles at Hill-Rom and Baxter Healthcare. Alongside a $520,000 base salary, his compensation includes stock units and stock appreciation rights, with provisions for severance benefits under certain conditions. McCulloch’s extensive experience in pharmaceuticals and his education from the University of Michigan and Northwestern’s Kellogg School of Management position him as a strategic leader for the company’s future growth.
See more insights into XERS stock on TipRanks’ Stock Analysis page.